induce multidrug resist… | 0.48 |
prescribe information | 0.48 |
decrease the clearance … | 0.42 |
come as capsule | 0.34 |
increase plasma flutica… | 0.34 |
induce p-glycoprotein e… | 0.34 |
inhibit saquinavir's me… | 0.34 |
dosed with meal | 0.34 |
induce cyp2c9 | 0.25 |
demonstrate additive ef… | 0.25 |
regimen | 0.48 |
antiretroviral regimen | 0.34 |
reduced serum cortisol … | 0.53 |
a 174% | 0.42 |
used in combination | 0.58 |
administered with vincr… | 0.57 |
administered at doses o… | 0.42 |
co | 0.34 |
withheld for prolonged … | 0.34 |
approved for use | 0.25 |